Market Research Logo

Sanofi - Product Pipeline Review - 2016

Sanofi - Product Pipeline Review - 2016

Summary


Global Markets Direct’s, ‘Sanofi - Product Pipeline Review - 2016’, provides an overview of the Sanofi’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Sanofi, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Sanofi
  • The report provides overview of Sanofi including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Sanofi’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Sanofi’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Sanofi’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Sanofi
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Sanofi’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Sanofi Snapshot
Sanofi Overview
Key Information
Key Facts
Sanofi - Research and Development Overview
Key Therapeutic Areas
Sanofi - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Pipeline Products - Out-Licensed Products
Sanofi - Pipeline Products Glance
Sanofi - Late Stage Pipeline Products
Sanofi - Clinical Stage Pipeline Products
Sanofi - Early Stage Pipeline Products
Sanofi - Drug Profiles
(insulin glargine + lixisenatide)
lixisenatide
mipomersen sodium
semuloparin sodium
(fexofenadine hydrochloride + phenylephrine hydrochloride)
avanafil
cabazitaxel
insulin lispro
ziv-aflibercept (recombinant)
fexinidazole
(capecitabine + cyclophosphamide)
alemtuzumab
artefenomel + ferroquine
ataciguat
efpeglenatide
isatuximab
plerixafor
SAR-156597
sotagliflozin
pilaralisib
SAR-408701
SAR-421869
SAR-422459
voxtalisib
Monoclonal Antibodies to Inhibit Abeta for Alzheimer's Disease
SAR-113244
SAR-228810
SAR-366234
SAR-407899
SAR-425899
SAR-428926
SAR-438335
SAR-438544
SAR-440067
SAR-566658
ACP-003
DCM-1
efpeglenatide + HM-12470
food allergy vaccine
Peptides for Tuberculosis
Recombinant Proteins for Pseudomonas aeruginosa Infection
SAR-088
SAR-110068
SAR-131675
SAR-156497
SAR-184841
SAR-216471
SAR-224
SAR-244181
SAR-296968
SAR-396049
SAR-7334
Small Molecule 4 for Tuberculosis
Small Molecule to Inhibit Beta Sliding Clamp for Tuberculosis
Synthetic Peptide to Inhibit TIE-2 for Diabetic Foot Ulcers and Wounds
Monoclonal Antibodies for Infectious Disease
Monoclonal Antibodies for Neurodegenerative Diseases
Peptide for HIV and HSV Infections
SAR-405
Small Molecule 2 for Tuberculosis
Small Molecule 3 for Tuberculosis
Small Molecule for Calcific Aortic Valve Stenosis
Small Molecule for Duchenne Muscular Dystrophy
Small Molecules for Malaria
Small Molecules to Inhibit Protein Kinase for Undisclosed Indication
Vaccine for Celiac Disease
Vaccine for Food Allegy 2
Zika virus vaccine
Sanofi - Pipeline Analysis
Sanofi - Pipeline Products by Target
Sanofi - Pipeline Products by Route of Administration
Sanofi - Pipeline Products by Molecule Type
Sanofi - Pipeline Products by Mechanism of Action
Sanofi - Recent Pipeline Updates
Sanofi - Dormant Projects
Sanofi - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
Sanofi - Company Statement
Sanofi - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Sanofi - Key Manufacturing Facilities
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Sanofi, Key Information
Sanofi, Key Facts
Sanofi - Pipeline by Indication, 2016
Sanofi - Pipeline by Stage of Development, 2016
Sanofi - Monotherapy Products in Pipeline, 2016
Sanofi - Combination Treatment Modalities in Pipeline, 2016
Sanofi - Partnered Products in Pipeline, 2016
Sanofi - Partnered Products/ Combination Treatment Modalities, 2016
Sanofi - Out-Licensed Products in Pipeline, 2016
Sanofi - Out-Licensed Products/ Combination Treatment Modalities, 2016
Sanofi - Pre-Registration, 2016
Sanofi - Filing rejected/Withdrawn, 2016
Sanofi - Phase III, 2016
Sanofi - Phase II, 2016
Sanofi - Phase I, 2016
Sanofi - Preclinical, 2016
Sanofi - Discovery, 2016
Sanofi - Pipeline by Target, 2016
Sanofi - Pipeline by Route of Administration, 2016
Sanofi - Pipeline by Molecule Type, 2016
Sanofi - Pipeline Products by Mechanism of Action, 2016
Sanofi - Recent Pipeline Updates, 2016
Sanofi - Dormant Developmental Projects,2016
Sanofi - Discontinued Pipeline Products, 2016
Sanofi, Subsidiaries
Sanofi, Key Manufacturing Facilities
List of Figures
Sanofi - Pipeline by Top 10 Indication, 2016
Sanofi - Pipeline by Stage of Development, 2016
Sanofi - Monotherapy Products in Pipeline, 2016
Sanofi - Combination Treatment Modalities in Pipeline, 2016
Sanofi - Partnered Products in Pipeline, 2016
Sanofi - Out-Licensed Products in Pipeline, 2016
Sanofi - Pipeline by Top 10 Target, 2016
Sanofi - Pipeline by Route of Administration, 2016
Sanofi - Pipeline by Top 10 Molecule Type, 2016
Sanofi - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report